Mayinglong Pharmaceutical Group Co., Ltd. Class ASSE: 600993

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Mayinglong Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Mayinglong Pharmaceutical Group Co., Ltd. Class A

All Mayinglong Pharmaceutical Group Co., Ltd. Class A news releases